Freenome, Inc. (FRNM) stock
FRNMNasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026
$10.41−0.20 (-1.89%)
Close on Nov 13, 2026Market cap $1.15BP/E –Yield –
Freenome EV/EBITDA
EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.
No ev/ebitda figures for Freenome
Freenome has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?